- Home
- EXEL vs ASTS Comparison
EXEL vs ASTS Comparison
Compare EXEL & ASTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | ASTS |
|---|---|---|
| Founded | 1994 | 2019 |
| Country | United States | United States |
| Employees | N/A | 1126 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 16.4B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | ASTS |
|---|---|---|
| Price | $56.10 | $63.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 8 |
| Target Price | $46.50 | ★ $72.10 |
| AVG Volume (30 Days) | 2.5M | ★ 16.0M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.95 | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $452,477,000.00 | N/A |
| Revenue This Year | $13.61 | $167.10 |
| Revenue Next Year | $13.13 | $391.80 |
| P/E Ratio | $70.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.76 | $39.50 |
| 52 Week High | $57.57 | $133.86 |
Technical Indicators
Market Signals| Indicator | EXEL | ASTS |
|---|---|---|
| Relative Strength Index (RSI) | 60.64 | 40.63 |
| Support Level | $40.77 | $49.31 |
| Resistance Level | $57.57 | $95.17 |
| Average True Range (ATR) | 1.41 | 5.88 |
| MACD | -0.17 | -1.25 |
| Stochastic Oscillator | 69.69 | 25.52 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ASTS AST SpaceMobile Inc.
AST SpaceMobile Inc is currently designing, developing and manufacturing the constellation of BlueBird (BB) satellites and has begun launching its planned space-based Cellular Broadband network distributed through a constellation of low Earth orbit (LEO) satellites. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.